Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate

Duffel M.W. (1997): Sulfotransferases. In: Guengerich F.P. (ed). Comprehensive Toxicology Vol.3, Biotransformation. Oxford: Elsevier, 365–383.

Chou H.C., Ozawa S., Fu P.P., Lang N.P., Kadlubar F.F. (1998): Metabolic activation of methyl-hydroxylated derivatives of 7,12-dimethylbenz[a]anthracene by human liver dehydroepiandrosterone-steroid sulfotransferase. Carcinogenesis, 19, 1071–1076.

Banoglu E. (2000): Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. Curr. Drug Metab., 1, 1–30.

King R.S., Teitel C.H., Kadlubar F.F. (2000): In vitro bioactivation of N-hydroxy-2-amino-α-carboline. Carcinogenesis, 21, 1347–1354.

Niwa T., Ise M. (1994): Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J. Lab. Clin. Med., 124, 96–104.

Niwa T., Ise M., Miyazaki T. (1994): Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am. J. Nephrol., 14, 207–212.

Niwa T., Takeda N., Tatematsu A., Maeda K. (1988): Accumulation of indoxyl sulfate, an inhibitor of drug binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin. Chem., 34, 2264–2267.

Sims J., Renwick A.G. (1985): The microbial metabolism of tryptophan in rats fed a diet containing 7.5% saccharin in a two-generation protocol. Food Chem. Toxicol., 23, 437–444.

Banoglu E., Jha G.G., King R.S. (2001): Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate. Eur. J. Drug Metab. Pharmacokin., 26(4), 1–6.

Sekura R.D., Jakoby W.B. (1979): Phenol Sulfotransferases. J. Biol. Chem., 254, 5658–5663.

Ademola J.I., Wester R.C., Maibach H.I. (1993): Metabolism of 3-indolylacetic acid during percutaneous absorption in human skin. J. Pharm. Sci., 82, 150–154.

Russel G.A., Kaupp G. (1969): Oxidation of carbanions. IV. Oxidation of indoxyl to indigo in basic solution. J. Am. Chem. Soc., 91, 3851–3859.

Perella F.W. (1988): A practical curve-fitting microcomputer program for the analysis of enzyme kinetic data on IBM-PC compatible computers. Anal. Biochem., 174, 437–447.

Duffel M.W., Binder T.P., Rao S.I. (1989): Assay of purified aryl sulfotransferase suitable for reactions yielding unstable sulfuric acid esters. Anal. Biochem., 183, 320–324.

Frame L.T., Ozawa S., Nowell S.A., Chou H.C., DeLongchamp R.R., Doerge D.R., Lang N.P., Kadlubar, F.F. (2000): A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols. Drug Metab. Dispos., 28, 1063–1068.

Campbell N.R.C., Van Loon J.A., Weinshilboum R.M. (1987): Human liver phenol sulfotrasferase: Assay conditions, biochemical-properties and partial purification of isozymes of the thermostable form. Biochem. Pharmacol., 36, 1435–1446.

Banoglu E., Duffel M.W. (1997): Studies on the interactions of chiral secondary alcohols with rat hydroxysteroid sulfotransferase STa. Drug Metab. Dispos., 25, 1304–1310.

Rein G., Glover V., Sandler M. (1982): Multiple forms of phenolsulphotransferase in human tissues. Biochem. Pharmacol., 31, 1893–1897.

Hernandez J.S., Watson W.G., Wood T.C., Weinshilboum R.M. (1992): Sulphation of estrone and 17b-estradiol in human liver: Catalysis by thermostable phenol sulfotransferase and by dehydroepiandrosterone sulfotransferase. Drug Metab. Dispos., 20, 413–422.

Koster H., Halsema I., Scholtens E., Meerman J.H.N., Pang S., Mulder G.J. (1982): Selective inhibition of sulfate conjugation in the rat. Biochem. Pharmacol., 31, 1919–1924.

Watabe T., Hiratsuka A., Ogura K. (1987): Sulphotransferase-mediated covalent binding of the carcinogen 7,12-dihydroxymethyl[a]anthracene to calf thymus DNA and its inhibition by glutathione transferase. Carcinogenesis, 8, 445–453.

Chen G., Banoglu E., Duffel M.W. (1996): Influence of substrate structure on the catalytic efficiency of hydroxysteroid sulfotransferase STa in the sulfation of alcohols. Chem. Res. Toxicol., 9, 67–74.

Falany C.N., Krasnykh V., Falany J.L. (1995): Bacterial expression and characterisation of a cDNA for human liver estrogen sulfotransferase. J. Steroid Biochem. Mol. Biol., 52, 529–539.

Niwa T. (1996): Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Sem. Nephrol., 16, 167–182.

Miyazaki T., Ise M., Seo H., Niwa T. (1997): Indoxyl sulfate increases the gene expressions of TGF-b1 and pro-a1(I) collagen in uremic rat kidneys. Kidney Int., 52, S15-S22.

Sakai T., Takadate A., Otagiri M. (1995): Characterization of binding site of uremic toxins on human serum albumin. Biol. Pharmaceut. Bull., 18, 1755–1761.

Raftogianis R.B., Wood T.C., Weinshilboum R.M. (1999): Human phenol sulfotransferases SULT1A2 and SULT1A1. Biochem. Pharmacol., 58, 605–616.

Price R.A., Spielman R.S., Lucena A.L., Van Loon J.A., Maidak B.L., Weinshilboum R.M. (1989): Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity. Genetics, 122, 905–914.